Document is current

Any future updates will be listed below

A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s12894-016-0163-5

Published Online: 2016-08-02

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark